Rentokil Initial - RTO Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $31.90
  • Forecasted Upside: 36.85%
  • Number of Analysts: 13
  • Breakdown:
  • 1 Sell Ratings
  • 5 Hold Ratings
  • 7 Buy Ratings
  • 0 Strong Buy Ratings
$23.31
▲ +0.05 (0.21%)

This chart shows the closing price for RTO by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Rentokil Initial Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RTO and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RTO

Analyst Price Target is $31.90
▲ +36.85% Upside Potential
This price target is based on 13 analysts offering 12 month price targets for Rentokil Initial in the last 3 months. The average price target is $31.90, with a high forecast of $35.00 and a low forecast of $26.70. The average price target represents a 36.85% upside from the last price of $23.31.

This chart shows the closing price for RTO for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 13 investment analysts is to hold stock in Rentokil Initial. This rating has held steady since August 2026, when it changed from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 2 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
5/8/2025
  • 1 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
8/6/2025
  • 2 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 1 sell ratings
11/4/2025
  • 1 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 2 sell ratings
2/2/2026
  • 1 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 2 sell ratings
5/3/2026
  • 1 strong buy ratings
  • 7 buy ratings
  • 4 hold ratings
  • 2 sell ratings
8/1/2026
  • 1 strong buy ratings
  • 7 buy ratings
  • 5 hold ratings
  • 1 sell ratings
9/30/2026
  • 0 strong buy ratings
  • 7 buy ratings
  • 5 hold ratings
  • 1 sell ratings
10/30/2026

Latest Recommendations

  • 0 strong buy ratings
  • 7 buy ratings
  • 5 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/22/2026Zacks ResearchUpgradeStrong Sell ➝ Hold
10/13/2026Weiss RatingsDowngradeHold (C-) ➝ Sell (D+)
10/5/2026The Goldman Sachs GroupReiterated RatingBuy ➝ Buy
10/5/2026Stifel NicolausUpgradeHold ➝ Buy
9/29/2026Morgan StanleyDowngradeOverweight ➝ Equal Weight
9/23/2026InvestecUpgradeBuy
8/20/2026Weiss RatingsDowngradeHold (C) ➝ Hold (C-)
8/3/2026Deutsche Bank AktiengesellschaftReiterated RatingHold ➝ Hold
7/31/2026BNP Paribas ExaneDowngradeOutperform ➝ Neutral$26.70
7/6/2026The Goldman Sachs GroupUpgradeNeutral ➝ Buy
6/24/2026Weiss RatingsReiterated RatingHold (C) ➝ Hold (C)
6/15/2026Zacks ResearchDowngradeHold ➝ Strong Sell
5/4/2026Zacks ResearchUpgradeStrong Sell ➝ Hold
3/12/2026UBS GroupUpgradeNeutral ➝ Buy
3/11/2026Rothschild & Co RedburnUpgradeSell ➝ Neutral
3/10/2026OppenheimerBoost TargetOutperform ➝ Outperform$30.00 ➝ $35.00
3/4/2026Zacks ResearchDowngradeHold ➝ Strong Sell
2/24/2026Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold
1/30/2026Rothschild & Co RedburnDowngradeHold ➝ Strong Sell
1/22/2026Weiss RatingsReiterated RatingHold (C-) ➝ Hold (C-)
1/6/2026Morgan StanleyUpgradeEqual Weight ➝ Overweight
12/18/2025Bank of AmericaUpgradeNeutral ➝ Buy$34.00
11/21/2025JPMorgan Chase & Co.Reiterated RatingOverweight
10/10/2025Zacks ResearchUpgradeStrong Sell ➝ Hold
10/8/2025Jefferies Financial GroupUpgradeStrong-Buy
10/8/2025Weiss RatingsReiterated RatingHold (C-) ➝ Hold (C-)
10/7/2025Sanford C. BernsteinUpgradeUnderperform ➝ Outperform
9/29/2025Berenberg BankUpgradeStrong Sell
9/27/2025Weiss RatingsReiterated RatingHold (C-) ➝ Hold (C-)
7/21/2025Deutsche Bank AktiengesellschaftReiterated RatingBuy ➝ Buy
5/15/2025Sanford C. BernsteinDowngradeMarket Perform ➝ Underperform
3/7/2025Deutsche Bank AktiengesellschaftReiterated RatingBuy ➝ Buy
12/13/2024CitigroupUpgradeStrong-Buy
9/19/2024Rothschild & Co RedburnDowngradeBuy ➝ Neutral
7/26/2024BarclaysUpgradeStrong-Buy
7/22/2024Sanford C. BernsteinUpgradeUnderperform ➝ Market Perform
7/1/2024UBS GroupUpgradeSell ➝ Neutral
4/23/2024JPMorgan Chase & Co.Initiated CoverageNeutral
3/18/2024BNP Paribas ExaneUpgradeNeutral ➝ Outperform
1/24/2024Bank of AmericaDowngradeBuy ➝ Neutral$40.00 ➝ $29.00
10/5/2023Societe GeneraleInitiated CoverageSell
5/22/2023OppenheimerBoost Target$40.00 ➝ $47.00
3/22/2023BNP Paribas ExaneUpgradeUnderperform ➝ Neutral
3/7/2023BarclaysInitiated CoverageOverweight ➝ Overweight
10/21/2022The Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral
(Data available from 10/30/2021 forward)

News Sentiment Rating

0.61 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/3/2026
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/3/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/2/2026
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/2/2026
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/1/2026
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/31/2026
  • 0 very positive mentions
  • 2 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
9/30/2026
  • 12 very positive mentions
  • 9 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
10/30/2026

Current Sentiment

  • 12 very positive mentions
  • 9 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Rentokil Initial logo
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers. The company provides hygiene services, including the provision and maintenance of products, such as soap and hand sanitizer dispensers, hand dryers, air care and purification, cubicle and surface sanitizers, feminine hygiene units, toilet paper dispensers, and floor protection mats. In addition, it engages in the supply and maintenance of workwear and protective equipment. Further, the company offers property care services; and provides a range of specialist cleaning services, such as graffiti removal deep cleaning of kitchens and washrooms, trauma cleaning, and flood or fire damage cleaning, as well as specialist medical and hygiene services. Rentokil Initial plc was founded in 1903 and is headquartered in Crawley, the United Kingdom.
Read More

Today's Range

Now: $23.31
Low: $23.26
High: $23.59

50 Day Range

MA: $21.89
Low: $19.77
High: $24.28

52 Week Range

Now: $23.31
Low: $19.50
High: $34.67

Volume

1,861,270 shs

Average Volume

1,818,243 shs

Market Capitalization

$11.78 billion

P/E Ratio

N/A

Dividend Yield

1.54%

Beta

1.01

Frequently Asked Questions

What sell-side analysts currently cover shares of Rentokil Initial?

The following Wall Street research analysts have issued research reports on Rentokil Initial in the last twelve months: Bank of America Corporation, BNP Paribas Exane, Deutsche Bank Aktiengesellschaft, Investec, JPMorgan Chase & Co., Morgan Stanley, Oppenheimer Holdings, Inc., Rothschild & Co Redburn, Stifel Nicolaus, The Goldman Sachs Group, Inc., UBS Group AG, Wall Street Zen, Weiss Ratings, and Zacks Research.
View the latest analyst ratings for RTO.

What is the current price target for Rentokil Initial?

0 Wall Street analysts have set twelve-month price targets for Rentokil Initial in the last year. Their average twelve-month price target is $31.90, suggesting a possible upside of 36.9%. Oppenheimer Holdings, Inc. has the highest price target set, predicting RTO will reach $35.00 in the next twelve months. BNP Paribas Exane has the lowest price target set, forecasting a price of $26.70 for Rentokil Initial in the next year.
View the latest price targets for RTO.

What is the current consensus analyst rating for Rentokil Initial?

Rentokil Initial currently has 1 sell rating, 5 hold ratings and 7 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in RTO, but not buy more shares or sell existing shares.
View the latest ratings for RTO.

What other companies compete with Rentokil Initial?

How do I contact Rentokil Initial's investor relations team?

Rentokil Initial's physical mailing address is Compass House, Crawley, WSX, RH10 9PY. The company's listed phone number is 441293858000 and its investor relations email address is [email protected]. The official website for Rentokil Initial is www.rentokil-initial.com. Learn More about contacing Rentokil Initial investor relations.